Judith Swain

Judith Swain

Directeur/Membre du Conseil chez LEXICON PHARMACEUTICALS, INC.

Fortune : 380 379 $ au 31/05/2026

77 ans
Consumer Services
Health Technology
Commercial Services

Profil

Judith L.
Swain
is the founder of Synecor LLC, founded in 2000.
Current jobs include Independent Director at Lexicon Pharmaceuticals, Inc. since 2007; Director at Wellcome Leap, Inc. since 2024; Director at Lee Kong Chian School of Medicine; Director at Upstream Medical Technologies Ltd.; Council Member at National Academy of Medicine (United States) since 2013; Member at National Academies of Sciences; and Chief Medical Officer at PhysioWave, Inc. since 2016.
Former jobs include Chairman-Medical Faculty at Duke University; Chairman-Medicine Department at Stanford University from 1997 to 2005; Chairman-Medical Faculty at the University of Pennsylvania; Director at Predicant Biosciences, Inc.; Executive Director at Agency for Science, Technology & Research; Director at The Burroughs Wellcome Fund; Director at National Healthcare Group Pte Ltd.; Director at AVACEN, Inc.; Executive Director at Singapore Institute For Clinical Sciences; Independent Director at Prometheus Biosciences, Inc. from 2021 to 2023; Professor at National University of Singapore from 2006 to 2017; and Dean at the University of California San Diego from 2005 to 2006.
Education includes undergraduate degree from the University of California, Los Angeles and doctorate from the University of California San Diego.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
03/06/2026 174 486 ( 0,04 % ) 380 379 $ 31/05/2026

Postes actifs de Judith Swain

SociétésPosteDébut
LEXICON PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/09/2007
Directeur/Membre du Conseil -
Directeur Technique/Scientifique/R&D 01/07/2016
Directeur/Membre du Conseil -
Corporate Officer/Principal -
Corporate Officer/Principal -
Wellcome Leap, Inc.
Directeur/Membre du Conseil 01/01/2024

Anciens postes connus de Judith Swain

SociétésPosteFin
PROMETHEUS BIOSCIENCES, INC. Directeur/Membre du Conseil 16/06/2023
Corporate Officer/Principal 01/01/2017
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Judith Swain

Formation de Judith Swain

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

91

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées21

Health Technology

Finance

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Miscellaneous

Commercial Services

Health Services

Commercial Services

Consumer Services

Health Technology

Singapore Institute For Clinical Sciences

Commercial Services

Health Technology

Health Technology

Wellcome Leap, Inc.

  1. Bourse
  2. Insiders
  3. Judith Swain
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇